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Abstract 
Spontaneous dizygotic (DZ) twinning occurs in 1-4% of women, with familial clustering and 
unknown pathophysiological pathways and genetic origin. DZ twinning may index increased 
fertility and has distinct health implications for mother and child. We performed the first a 
GWA study in 1,980 mothers of spontaneous DZ twins and 12,953 controls. Findings were 
replicated in a large Icelandic cohort and tested for association across a broad range of fertility 
traits in women. Two SNPs were identified (rs11031006 near FSHB, p = 1.54 × 10
-9
, and 
rs17293443 in SMAD3, p = 1.57 × 10
-8
) and replicated (p = 3 × 10
−3
 and p = 1.44 × 10
−4
, 
respectively). Based on ~90,000 births in Iceland, the relative risk of a mother delivering 
twins increased by 18% for each copy of the allele rs11031006-G, and 9% for the 
rs17293443-C. A higher polygenic risk score (PRS) for DZ twinning, calculated based on the 
results of the DZ twinning GWAS, was significantly associated with DZ twinning in Iceland 
(p = 0.001). A higher PRS was also associated with having children (p = 0.01), greater 
lifetime parity (p = 0.03) and earlier age at first child (p = 0.02). The Allele rs11031006-G 
was associated with higher serum FSH levels, earlier age at menarche, earlier age at first 
child, higher lifetime parity, lower PCOS risk, and earlier age at menopause. Conversely, the 
rs17293443-C was associated with later age at last child. We identified the first robust genetic 
risk variants for DZ twinning: one near FSHB, and a second within SMAD3,—the product of 
which plays an important role in gonadal responsiveness to FSH. These loci contribute to 
crucial aspects of reproductive capacity and health. 
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Introduction 1 
DZ twinning (MIM: 276400) is defined as the concomitant conception and 2 
development of two independent zygotes during one pregnancy. Mothers of spontaneous 3 
(conceived without assisted reproductive technology) DZ twins have a predisposition to 4 
multiple ovulation events due to interference with single dominant follicle selection, a 5 
biological mechanism fundamental for the human species.
1
 DZ twinning is common, with 6 
large regional differences from six per 1000 births in Asia to 40 per 1000 births in Africa,
2
 7 
whereas monozygotic twinning occurs around the world at a constant rate of around three to 8 
four per 1000 births.
3; 4
  DZ twinning rates also vary substantially over time. For example, in 9 
the US, the observed incidence of twin births increased by a factor of 1.9 between 1971 and 10 
2009.
5
 While a considerable part of the increase is attributable to fertility treatments, with an 11 
estimate of 36% of all twins born in the USA in 2011 resulting from assisted reproduction, the 12 
majority of twins are still conceived spontaneously. In addition to fertility treatments, 13 
increases in maternal age contribute to increases in twinning incidence.
3; 6
 14 
Twinning is associated with increased risks to mother and offspring, including higher 15 
risks of stillbirth, neonatal death and premature birth. Compared to singleton children, twins 16 
use more hospital resources, especially during the first year of life,
7
 with hospital costs in the 17 
first five years of life being as much as 3·3-fold higher.
8
 18 
Mothers of DZ twins differ from other women in that they are taller, have an increased 19 
BMI, are more often overweight and more often smoke before the twin pregnancy.
9
 Family 20 
history, increased parity and gravidity all increase the risk of spontaneous DZ twinning.
1; 3
 21 
Remarkably, twinning rates do not reflect average nutritional status of a population, as 22 
established from longitudinal studies in countries that experienced periods of starvation, such 23 
as the Dutch hunger winter. Above a specific, yet undetermined, threshold, nutrition seems to 24 
be of minimal importance for reproduction in general and also for twinning.
10
 These 25 
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observations all point to spontaneous twinning being a heritable trait and suggest the potential 26 
for polygenic inheritance. In a landmark study of twinning based on data from genealogic 27 
records from Utah,
11
 White and Wyshak established that the genotype of the mother, but not 28 
that of the father, affects the frequency of DZ twinning.  29 
  The underlying physiological mechanism for DZ twinning is the release and 30 
fertilization of two or more oocytes. Ovarian folliculogenesis and determination of ovulation 31 
quota are controlled both by circulating concentrations of follicle-stimulating hormone (FSH) 32 
and by intra-ovarian factors including the two oocyte growth factors, GDF9 (MIM: 601918) 33 
and BMP15 (MIM: 300247), as well as their cognate receptors.
12
 In the common marmoset 34 
monkey (subfamily Callitrichinae), DZ twins comprise the predominant litter size, and 35 
singletons are rarely, if ever, observed. On DNA sequencing, specific nonsynonymous 36 
substitutions were identified in GDF9, BMP15, BMP4 (MIM: 112262), and WFIKKN1 (MIM: 37 
608021) as having a role in Callitrichine twinning.
13
 These genes are among a larger set of 63 38 
candidate genes with a potential involvement in regulation of ovulation number and/or control 39 
of growth and body size.
14
 40 
Efforts to characterize the genes that contribute to DZ twinning in humans have not 41 
been successful. Candidate gene and genome-wide linkage studies failed to uncover common 42 
variants associated with DZ twinning,
15-19
 although one study reported rare variants in GDF9 43 
to be associated with DZ twinning.
18
 44 
DZ twinning has been suggested as a measure of human fertility both at the individual 45 
and at the population level.
20
 Spontaneous DZ twinning may be considered as a marker of 46 
high fertility, as it reflects the frequency of double ovulation, the probability of coitus within 47 
the appropriate time frame with fertilization of both ova, and maintenance of a multiple 48 
pregnancy.  49 
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The aim of this study was to perform the first a genome-wide association study 50 
(GWAS) in mothers of spontaneous DZ twins to identify relevant genomic regions and test 51 
their significance across a broad range of female fertility and reproductive traits including age 52 
at menarche, age at natural menopause, age at first and last child, and lifetime parity. Three 53 
twin registries, from the Netherlands, Australia and Minnesota (USA) had detailed 54 
information on spontaneous twinning in mothers of DZ twins, as well as genotype data. 55 
Replication of top hits for twinning was possible in the Icelandic population and for other 56 
measures of reproductive ageing in several large-scale population meta-analyses
21-24
. 57 
 58 
Material and Methods 59 
Details of methods and associated references can be found in the supplemental data. 60 
Descriptions of Participating Studies 61 
Netherlands Twin Register (NTR) 62 
The NTR sample consisted of 806 cases and 4,535 controls from the Netherlands Twin 63 
Register (2,776 participants) and the Netherlands Study of Depression and anxiety (NESDA; 64 
2,565 participants). NTR participants were ascertained by the presence of liveborn twins or 65 
triplets in the family and consist of multiples, their parents, siblings and spouses. Twins were 66 
born in all strata of society and NTR represents a general sample from the Dutch population
25-
67 
28
. NESDA is a longitudinal study focusing on the course and consequences of depression and 68 
anxiety disorders. Subjects for NESDA were recruited from the general population, mental 69 
health organizations and general practices. The sample includes subjects selected for 70 
depression and anxiety, as well as healthy controls
29
. Zygosity of twins was confirmed by 71 
DNA genotyping. Data on mode of pregnancy were available from several data collection 72 
waves including surveys sent out to mothers of twins, a survey to parents upon registration of 73 
young twins, and telephone interview as part of a project on DZ twinning
9
. The comparison of 74 
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the survey data with the hospital records showed that mothers can accurately report on the 75 
mode of conception of their twins
30
. Participants were excluded if they reported the use of 76 
assisted reproductive technology at one or more occasions. In case no reports on mode of 77 
pregnancy were available, data were excluded unless the twins were born prior to 1985. 78 
QIMR Berghofer Medical Research Institute (QIMR) 79 
The sample used in this analysis consisted of 606 cases and 6,656 controls. The individuals 80 
were drawn from families containing (any type of) twins recruited for prior studies, either 81 
from around Australia from the Australian Twin Registry (ATR) (generally twins born before 82 
1971) or from south-eastern Queeensland (generally twins born after 1980). Study recruitment 83 
was predominantly population based (any family where the twins were willing to participate) 84 
with no screening performed on reproductive phenotypes apart from selecting families with 85 
twins. Studies for the older cohort typically were focused on personality traits but not selected 86 
for them. Zygosity of twins was reported at time of recruitment; during phenotyping studies; 87 
and tested by genotyping (on SNP arrays or Sequenom assays). New phenotyping excluded 88 
mothers (‘cases’) from Queensland cohort, who used Assisted Reproductive Technology 89 
(ART–typically IVF or hormone treatment) to become pregnant. Screening questions asked of 90 
the mother during clinical sessions for phenotyping, were the primary basis for excluding 91 
ART cases. A smaller subset of mothers was contacted specifically to establish this 92 
information where it was not otherwise available. For the older (ATR) cohort, at the time of 93 
the twins’ birth, IVF was not yet in clinical use and other ART was rare.  94 
Minnesota Center for Twin and Family Research (MCTFR) 95 
All subjects in this sample were independently ascertained through vital records of the State 96 
of Minnesota in an effort to construct a population-based twin registry
31; 32
. The sample for 97 
the current study consisted of 568 mothers of DZ twins and 1,862 controls who were the 98 
parents of MZ twins from 1,062 families, including 800 complete parental pairs, 203 mothers 99 
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and 59 fathers. Most of the twins were born in the 70s or early 80s, when even though fertility 100 
treatment was available in the US, it was expensive and few had access to it. Genotyping was 101 
population-based and independent of phenotypes other than twinning. About 92% of the 102 
registry, and 100% of both case and control samples, are of primarily European ancestry. 103 
Iceland (deCODE)  104 
Mothers of twins or other multiples (“twins”) were selected from among those taking part in 105 
deCODE’s genetic studies based on a nationwide genealogical database. To increase the 106 
proportion of these mother of twins who were mothers of dizygotic twins, twins who had been 107 
genotyped and shown to be monozygotic were not used to identify mothers. Controls were 108 
individuals participating in deCODE’s genetic research from which both mothers of twins and 109 
the mothers’ first-degree relatives had been removed. For the prediction of twinning using 110 
polygenic risk scores, mothers having opposite sex or verified dizygotic twins were compared 111 
with mothers who did not have twins. 112 
 113 
Study Design, Genome-Wide Association Study and Replication 114 
We established the Twinning GWAS Consortium (TGC) to characterize the genetic basis of 115 
DZ twinning in humans and performed the first  a genome-wide association study (GWAS) 116 
for DZ twinning utilizing data from 1,980 mothers of DZ twins (MODZT) and 12,953 117 
controls from The Netherlands, US and Australian European ancestry cohorts. Sample sizes 118 
and study characteristics are described in table S1. All cases underwent screening to exclude 119 
mothers who received assisted reproductive techniques. Controls were screened to exclude 120 
pedigrees containing DZ twins. In the replication stage, significant findings from the meta-121 
analysis were tested in large Icelandic cohort of 3,597 mothers of twins and 297,348 controls. 122 
All participants provided written informed consent, including consent for genotyping and 123 
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analysis, and were recruited according to the protocols approved by the institution review 124 
board of each institution. 125 
 126 
Fertility Traits Measures  127 
Fertility measures (having children, number of children, age at first and last child and average 128 
birth interval) were defined in females born before 1970 based on the Icelandic genealogy. 129 
Data for age at menarche, age at menopause and polycystic ovary syndrome were derived 130 
from previously published GWAS consortia
21-24
. Sample sizes and study characteristics are 131 
described in table 2. 132 
 133 
Genotyping, Quality Control and Imputation 134 
Each participating cohort performed participant-level genotyping of single nucleotide 135 
polymorphisms (SNPs), that included standard quality-control measures for genotyping and 136 
imputation (Table S21 and Supplemental Methods). All imputations were performed using the 137 
1000 Genomes Project March 2012 release as the reference panel.  138 
Statistical analysis 139 
GWA analysis was performed in each cohort using logistic regression under an additive 140 
genetic model with adjustment for principal components of genetic ancestry and specific 141 
covariates for each study. GWA results for each SNP (odds ratio [OR] and 95% confidence 142 
interval [CI]) were combined across cohorts using fixed-effect meta-analysis with inverse 143 
variance weighting. The most significant SNP at each genome-wide significant (p<5×10
-8
) 144 
locus was tested in the replication stage and replicating SNPs were examined for association 145 
with FSH levels and other fertility traits. 146 
Association Tests 147 
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Each genome-wide association analysis from the three cohorts was conducted using logistic 148 
regression under an additive genetic model with adjustment for principal components of 149 
genetic ancestry. Because the GWAS data include family members we added the –family 150 
option in the analysis, which takes the familial structure of the data into account using a 151 
sandwich estimator
33
. Imputed SNPs were analyzed using PLINK software
34
 and genotype 152 
imputation uncertainty was accounted for by using allelic dosage in PLINK. 153 
Meta-analysis was performed using the fixed-effects inverse variance method based on the 154 
regression β estimates and standard errors from each study implemented in METAL35. The 155 
presence of heterogeneity between cohorts for the effect sizes of risk alleles was investigated 156 
using the Cochran’s Q-test as implemented in METAL. To determine whether the genome-157 
wide significant signal at each locus with low LD in the same chromosomal region (defined 158 
as r
2
 < 0.05 in a 750-kb region) could be accounted for by a single SNP, we carried out 159 
conditional analysis. Each cohort performed a genome-wide analysis for MODZT using 160 
logistic regression adjusting for the top signal at each of the three associated regions to 161 
determine whether potential second signals remained significant even after adjusting for these 162 
variants. Results from each individual study were meta-analyzed to determine whether these 163 
potential second signals were truly independent (that is, if p < 5 × 10
-8
). In Iceland, being a 164 
mother of twins was tested for association with the top alleles using logistic regression and 165 
including age, age-squared and county of birth as covariates as described previously
36
. 166 
Associations between FSH level and genotype was assessed using linear regression as 167 
described previously
36
. To study the association of fertility measures and SNP genotype, we 168 
used logistic regression (having children), Poisson log-linear regression (number of children), 169 
or linear regression (age at first child, age at last child, and average birth interval). In these 170 
analyses, birth cohort (as a factor for each five year interval), county of birth and six principal 171 
components were included as covariates. Relatedness was controlled for by using genomic 172 
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control in all Icelandic association analyses
37
. The combined p value of the meta-analysis and 173 
the replication study was calculated using Fisher’s combined probability test38.  174 
 175 
FSH Serum Level Measure 176 
Serum levels of follicle-stimulating hormone (FSH) were measured in 2,411 men (1,275 177 
genotyped persons; 1,136 close relatives of genotyped individuals) and 15,586 women (9,738 178 
genotyped persons; 5,848 close relatives of genotyped individuals) referred to three clinics in 179 
Iceland. FSH testing was undertaken primarily to investigate possible gonad impairment. 180 
Hormone levels were measured by electrochemiluminescence immunoassay, using reagents 181 
and analytical instruments from Roche Diagnostics GmbH, according to the manufacturer’s 182 
instructions.  183 
 184 
In silico Functional Annotation 185 
 We used a number of publicly available bioinformatics tools and datasets to identify putative 186 
functional effects of the top associated SNPs at each locus, including: Combined Annotation 187 
Dependent Depletion (CADD)
39
, HaploReg2 v4
40
 and Variant effect predictor (VEP)
41
 .  188 
 189 
Gene Based Test 190 
Results of the MODZT meta-analysis were used to perform a gene-based test of association 191 
for the 63 candidate genes from Harris et al. using the Knowledge-based mining system for 192 
Genome-wide Genetic studies (KGG) software Version 3.5
42; 43
. This approach uses an 193 
extended Simes test that integrates prior functional information and the meta-analysis 194 
association results when combining the SNP p values within a gene in order to obtain an 195 
overall association p value for each entire gene. As we tested for genetic association for 63 196 
genes, the significance level was set at 7.93 × 10
-4
 (Bonferroni correction; 0.05/63). 197 
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 198 
Polygenic Risk Scores (PRS) 199 
Polygenic risk scores were calculated based on the results of the MODZT meta-analysis. Only 200 
markers having info > 0.9 in all groups and MAF > 0.01 were included. To obtain effect sizes 201 
taking LD into account, the LDpred method developed by Vilhjálmsson and colleagues was 202 
used
44
. As suggested by Vilhjálmsson et al, we calculated multiple sets of LD-modified effect 203 
sizes based on a grid of values for the fraction of causal markers (α = 0.0001, 0.0003, 0.001, 204 
0.003, 0.01, 0.03, 0.1, 0.3, 1). The resulting scores were then tested in a validation data set of 205 
Icelandic mothers of dizygotic twins. The score producing the most significant result in the 206 
validation data set were subsequently used to test for association with five fertility-related 207 
traits (“has children”, “number of children”, “age at first child”, “age at last child” and 208 
“average birth interval”). 209 
 210 
Results  211 
Genome-wide association results, replication and gene based analyses 212 
The overall GWAS meta-analysis genomic control statistic (λ) was 1.01, indicating no 213 
appreciable inflation due to population structure. The quantile-quantile (Q-Q) plot of genome-214 
wide p values showed a strong deviation from the null hypothesis of no association (Figure 215 
S1). The results are represented in the Manhattan plot (Figure 1). Three chromosomal regions 216 
contained genome-wide significant SNPs (p < 5 × 10
-8
). Twenty-two SNPs on chromosome 217 
11p13 showed genome-wide significant associations. Of these, the strongest signal 218 
(rs11031006, p = 1.54 × 10
-9
 and OR 1.41, 95% CI 1.29-1.53) lies in the region 5’ of the 219 
transcription start site of FSHB (encoding the FSH, beta polypeptide, [MIM: 136530]). A 220 
second locus was represented by five SNPs on 1q42.13 covering an intergenic region flanked 221 
by PGBD5 (MIM: 616791) and COG2 ([MIM: 606974]), (p = 1.23 × 10
-8
, OR 1.43, 95% CI 222 
13 
 
1.31-1.55 for strongest signal, rs12064669). A third locus on 15q22.33, mapped to the first 223 
intron of SMAD3  (SMAD family member 3, [MIM: 603109]) (rs17293443, p = 1.57 × 10
-8
 224 
and OR 1.27, 95% CI 1.19-1.35). No significant heterogeneity in SNP effects was observed 225 
across cohorts for the top SNPs (p  >  0.1, Cochran’s Q test) ; Tables 1 3 and S23). The 226 
regional association plots for these loci are shown in figure S2. After conditioning on the top 227 
SNPs at each locus, no secondary signals were observed (all p > 0.05; Tables S43, S54 and 228 
S65). We sought validation of these three top signals in an independent replication study from 229 
Iceland (deCODE) totaling 3,597 mothers of twins and 297,348 controls. The FSHB 230 
(rs11031006, p = 3 × 10
−3
, OR 1.14, 95% CI 1.06-1.22) and SMAD3 (rs17293443, p = 1.44 × 231 
10
−4
, OR 1.15, 95% CI 1.07-1.23) loci replicated, but rs12064669 (p=0.88) was not confirmed 232 
(Table 13 and Figure S32). We also investigated whether any of the proposed 63 candidate 233 
genes
14
 was associated with human DZ twinning. In a gene-based test, five genes 234 
demonstrated a nominally significant association (p < 0.05; BMPR1A [MIM: 601299], 235 
BMPR1B [MIM: 603248], IGF1 [MIM: 147440], FSHB and FSHR [MIM: 136435]). After 236 
correction for multiple testing, only FSHB remained significant (Table S76). 237 
 238 
Functional in silico annotation of associated variants 239 
We explored plausible functional effects of our associated variants using Combined 240 
Annotation Dependent Depletion (CADD).
39
 The FSHB SNP rs11031006 had a high Phred 241 
scaled C-score (22.4), indicating that it is among the top 1% of SNPs in the human genome 242 
most likely to have a functional effect. The Phred score for the SMAD3 SNP rs17293443 was 243 
only 2.71 indicating that it is among the bottom 50% of SNPs in the human genome likely to 244 
have a functional effect (Table S107). Examination of individual constituents of the CADD 245 
scores showed particularly high conservation-based scores for rs11031006 (Figure S63). To 246 
further investigate possible functional effects we examined data from the ENCODE project.
45
 247 
Field Code Changed
Field Code Changed
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The FSHB SNP rs11031006 alters the sequence of 11 protein-binding motifs including that of 248 
the Estrogen receptor alpha, indicating a possible effect on hormonal feedback inhibition 249 
(Table S118). Variant Effect Predictor (VEP)
41
 identified rs17293443 as a regulatory region 250 
variant within a promoter flanking region (ENSR00000410126) (Figure S74). SNP 251 
rs17293443 was contained in a DNase I hypersensitive site suggesting open chromatin, 252 
although it did not alter any of the transcription factor binding sites present in the promoter 253 
flanking region. Together, these data indicate that rs11031006 and rs17293443 may have 254 
direct functional roles. 255 
SNPs associated with FSH serum level 256 
We analyzed serum FSH measurements from 17,997 genotyped Icelanders and their close 257 
relatives. SNP rs11031006 was significantly associated with higher serum FSH levels (p = 2.3 258 
× 10
-10
), with each G allele conferring an increase in FSH level of about 0.11 SD units (Figure 259 
S54). Notably, the allele (rs11031006-G) conferring the strongest association with FSH levels 260 
in the FSH GWAS is the same allele that conferred the greatest chance of having DZ twins in 261 
our MODZT GWAS. No association was seen between the SMAD3 signal and serum FSH 262 
levels (p = 0.30). 263 
 264 
Relative risk of twin birth and polygenic risk score prediction of DZ twinning and 265 
fertility measures 266 
We estimated that the relative risk of a twin birth, based on approximately 90,000 births in 267 
Iceland between 1950 and 1991, was increased by 18% for each maternal rs11031006-G 268 
allele and by 9% for each rs17293443-C allele (Table S8). A higher polygenic risk score 269 
(PRS) for DZ twinning, calculated based on the results of the DZ twinning GWAS, was 270 
significantly associated with DZ twinning in our independent Icelandic cohort (p = 0.001) 271 
(Table S7). A higher PRS was also associated with a higher likelihood of having children (p = 272 
15 
 
0.01), higher lifetime number of children (p = 0.03), and an earlier age at first child (p = 0.02) 273 
(Table S98). A re-calculated PRS, excluding the 1 Mb regions surrounding the two replicated 274 
variants, remained associated with DZ twinning (p = 0.02) and with the likelihood of having 275 
children (p = 0.03). These results reflect the polygenic contribution to the susceptibility to DZ 276 
twinning and its association with greater reproductive ability. 277 
 278 
SNPs associated with female reproduction traits 279 
Table 24 reports on the two loci robustly implicated in DZ twinning and other reproductive 280 
traits in women. Consistent with its effects on higher circulating FSH levels, the rs11031006-281 
G allele is also associated with earlier age at menarche,
22; 46
 earlier age at first child and 282 
higher total lifetime number of children, lower risk of polycystic ovary syndrome (PCOS),
23
 283 
and earlier age at natural menopause.
24; 47
 Also, the DZ twinning SNP rs11031006 is 284 
correlated with a variant (rs10835638, FSHB-211G>T) located in the promoter of FSHB (r
2 
= 285 
0.62) that is associated with timing of breast development in girls.
48
 In contrast, the 286 
rs17293443-C allele in SMAD3 was associated only with a later age at last child (Figure S65). 287 
Functional in silico annotation of associated variants 288 
We explored plausible functional effects of our associated variants using Combined 289 
Annotation Dependent Depletion (CADD).
38
 The FSHB SNP rs11031006 had a high Phred 290 
scaled C-score (22.4), indicating that it is among the top 1% of SNPs in the human genome 291 
most likely to have a functional effect. The Phred score for the SMAD3 SNP rs17293443 was 292 
only 2.71 indicating that it is among the bottom 50% of SNPs in the human genome likely to 293 
have a functional effect (Table S10). Examination of individual constituents of the CADD 294 
scores showed particularly high conservation-based scores for rs11031006 (Figure S6). To 295 
further investigate possible functional effects we examined data from the ENCODE project.
44
 296 
The FSHB SNP rs11031006 alters the sequence of 11 protein-binding motifs including that of 297 
Field Code Changed
Field Code Changed
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the Estrogen receptor alpha, indicating a possible effect on hormonal feedback inhibition 298 
(Table S11). Variant Effect Predictor (VEP)
40
 identified rs17293443 as a regulatory region 299 
variant within a promoter flanking region (ENSR00000410126) (Figure S7). SNP rs17293443 300 
was contained in a DNase I hypersensitive site suggesting open chromatin, although it did not 301 
alter any of the transcription factor binding sites present in the promoter flanking region. 302 
Together, these data indicate that rs11031006 and rs17293443 may have direct functional 303 
roles. 304 
Discussion 305 
Here we report the first compelling evidence that sequence variation at the FSHB and 306 
SMAD3 loci increases the odds of DZ twinning. A number of studies in mothers of DZ twins, 307 
but not all,
49
 have found higher FSH levels responsible for multiple follicle growth.
50
 The 308 
associations of FSHB rs11031006-G with earlier ages at breast development, menarche, 309 
menopause, first child, and higher lifetime parity indicates that this locus plays an important 310 
role in multiple reproductive aspects. Female carriers of rs11031006-G likely may have a 311 
more advanced depletion of the ovarian follicular pool and hence would have an increased 312 
risk of premature ovarian failure (POF, [MIM: 612964]). Indeed advanced ovarian aging is a 313 
recognized feature of familial DZ twinning, with reported lower levels of anti-Mullerian 314 
Hormone (AMH) a marker of lower ovarian primordial follicular reserve.
51
 The rs17293443-315 
C allele in SMAD3 also increases chances of DZ twinning, but this effect appears independent 316 
of circulating FSH levels. 317 
Of the 63 suggested candidate genes for twinning, only FSHB was associated in gene-318 
based tests after correcting for multiple testing. Emerging data in human and non-human 319 
primates suggest that mechanisms underlying multiple ovulation may differ among species, 320 
explaining why in some species twinning is accompanied by unique evolutionary adaptations 321 
enabling offspring’s survival, such as the marmoset diminutive fetal size in a simplex uterus, 322 
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and subsequent alloparenting.
14
 Conversely, in humans, multiple gestations remain an 323 
independent risk factor for preterm birth, pregnancy loss, and fetal growth restriction. Thus 324 
loci common to species and strains with higher rates of DZ twinning will not necessarily be 325 
shared, as the rate, complications, and future reproductive fitness of those twin gestations 326 
differ. 327 
The third genome-wide hit from the discovery was not replicated in Iceland. SNP 328 
rs120644669 is located 149kb from the angiotensinogen (AGT, [MIM: 106150]), which 329 
influences ovulatory capacity in mice,
52
 and 89kb from component of oligomeric golgi 330 
complex 2 (COG2) affecting protein glycosilation, which regulates the biological activity of 331 
the pituitary gonadotrophins.
53
 332 
Genetic variants near FSHB (rs11031005 and rs11031002, which are highly correlated 333 
with rs11031006) are reportedly associated not only with higher serum FSH, but also lower 334 
LH levels.
54
 This agrees with the known response of the gonadotrophic cell to a high 335 
frequency hypothalamic pulsatile GnRH signal that reciprocally controls secretion of both 336 
hormones.
55
 Furthermore, under normal conditions suppression of FSH in the early follicular 337 
phase and higher LH levels in late phase typically favor mono-ovulation in the human.
56
 In a 338 
study aiming to identify genetic predictors for IVF success or IVF-controlled ovarian 339 
stimulation (COS), rs611246 located in FSHB (r
2 
= 0.3 with rs11031006), was reported 340 
significantly associated with measured early follicular phase FSH values and also with the 341 
probability of clinical pregnancy, suggesting that these genetic variants are potential predictor 342 
candidates that could be considered in clinical ovarian reserve and function assessment in 343 
assisted reproduction.
57
 344 
A recent linkage study in cattle reported only one strong signal (p < 1 × 10
-28
) for 345 
ovulation rate in a region spanning SMAD3, SMAD6 (MIM: 602931) and IQCH (MIM: 346 
612523).
58
 SMAD3 encodes one of a family of proteins that function as signal transducers and 347 
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transcriptional modulators that mediate multiple signaling pathways. Observations in mice 348 
have established an essential role for Smad3 in mediating TGFbeta and activin signals in the 349 
ovarian granulosa cell and also in the pituitary
59
 to maintain a favorable environment for 350 
oocyte maturation.
60
 Smad3 is strongly expressed in the human ovary, where it promotes 351 
granulosa cell proliferation and steroidogenesis possibly by upregulating gonadotrophin 352 
receptor signaling pathways.
61
 Thus, sequence variation in SMAD3 may increase chance of 353 
DZ twinning by increasing responsiveness to FSH. Understanding the role of SMAD3 will 354 
offer novel opportunities to optimize responsiveness and minimize risk among assisted 355 
reproduction technology (ART) recipients for example through adjustment of hormonal 356 
stimulation and thus contributes to prevention of life-threatening ovarian hyper stimulation 357 
syndrome in hyper responding female carriers of the rs17293443-C allele and conversely 358 
prevention of a poor response in patients individuals with allelic variants that lead to a poor 359 
response. 360 
The potential applications of this work in reproductive medicine are multifold. Firstly, 361 
it reveals a well-defined set of loci for DZ twinning in the general population. Secondly, 362 
twinning is associated with common perinatal morbidities such as preterm birth, discordant 363 
twin growth, latter prenatal asymmetric intrauterine growth restriction, and placental 364 
abruption. Multiple gestations are also related to a higher prevalence of maternal morbidities 365 
such as preeclampsia, postpartum hemorrhage, and ensuing complications. By understanding 366 
the genetic basis of DZ twinning, we concomitantly identify loci conferring susceptibility (or 367 
conversely resistance) to these prevalent perinatal comorbidities. The involvement of SMAD3 368 
is of relevance in the light of a possible phenotype in male DZ twins namely the repeatedly 369 
reported more frequent occurrence of testicular seminoma, a gonadal tumor in which the 370 
mitogenic cyclin D2 is overexpressed.
62; 63
 In animal experimental studies knockout of 371 
SMAD3 significantly attenuates cyclin D2 and tumor proliferation.
64
 This indicates to the 372 
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likely clinical potential of SMAD3 stretching beyond that of fertility physiology and 373 
treatment. 374 
This study The sequence variants found to influence spontaneous DZ twinning and 375 
their relationship with other fertility-related measures, provides important insights into 376 
ovarian functioning and the control of natural multiple follicle growth and reproductive aging. 377 
This has important implications for fertility, including improved outcome prediction and 378 
novel avenues of fertility treatment. Other strengths include the rigorous phenotype inclusion 379 
of mothers of DZ twins with a documented history of spontaneous DZ twinning. It is worth 380 
mentioning that analyses without excluding mothers who conceived their twins with hormone 381 
induction of multiple ovulation or other ART, did not yield to any genome-wide significant 382 
results (results not shown). We thus recommend twins registries collect data on mode of 383 
pregnancy of twins. There are also some limitations. The current effort focused on unraveling 384 
the genetic basis of DZ twinning in European-ancestry populations only. However, the 385 
highest incidence of DZ twins was reported in the Nigerian population and some other 386 
countries from Africa. Next steps in unraveling the genetic cause of DZ twinning need to 387 
include mothers of DZ twins originating from these regions, and if possible also from regions 388 
where DZ twinning is a rare trait, such as Japan
2
. 389 
In summary, we identified FSHB and the novel SMAD3 locus as maternal 390 
susceptibility loci for DZ twinning. These loci are also significantly and specifically 391 
associated with several other aspects of reproductive capacity and health. 392 
 393 
 394 
 395 
 396 
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Figures titles and legends 
Figure 1. Manhattan Plot for the genome-wide association meta-analysis of mothers of 
dizygotic twins. SNPs are plotted on the x-axis according to their position on each 
chromosome against the significance of the association on the y-axis (shown as –log10 p 
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values). The dotted red line denotes p=5×10
–8
 statistical significance. The arrows point to the 
chromosomal region that reached genome-wide significance level.  
Figure 2. Forest plots depicting risk allele odds ratio (OR) estimates at (A) rs11031006 (near 
FSHB), (B) rs17293443 (SMAD3) and (C) rs12064669 from each study, the meta-analysis, 
deCODE (replication) and the overall combined results. Black squares indicate the OR and 
horizontal lines represent the 95% CIs. The combined results are indicated by the black 
diamond. 
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Table 1. Number of cases and controls included in the meta-analysis and replication; mean 
maternal age at delivery 
Cohort 
No. of subjects 
Cases Controls Mean maternal 
age at delivery 
(SD) 
Netherlands 806 4,535 29.7 (4.1) 
Australia 606 6,556 29.8 (4.8) 
Minnesota 568 1,862 28.3 (4.5) 
Total discovery 1,980 12,953 29.3 (4.5) 
Replication    
Iceland  3,597 (1,356 genotyped; 2,241 
in silico) 
297,348   (76,342 genotyped; 
221,006 in silico) 
30.3 (5.8) 
 
 
Table 2. Sample characteristics for measure of fertility 
Traits  Sample size Mean (SD) 
Age at menarche 259,247 
-1
 
Age at menopause 
FSH levels 
69,360 
17,997 
-1
 
- 
Has children 
Number of children 
Age at first child 
Age at last child 
Average birth interval 
Polycystic ovary syndrome 
41,946 
41,946 
41,946 
41,946 
41,946 
5,184 cases / 82,759 controls 
0.94
2 
2.9 (1.6) 
23.0 (4.7) 
32.1 (5.5) 
4.7 (2.5) 
-1
 
1
 this is a large meta-analysis of summary statistics and sample mean is not available 
2
 fraction with children;  
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Table 13. Genome-wide significant loci in the meta-analysis of mothers of spontaneous DZ twins (n=1,980) and replication (n=3,597) versus screened 
controls 
 Meta-analysis  Replication  Combined 
SNP Locus Position
a
 Gene Annotation Risk 
allele 
RAF 
 
OR (95%CI) p  RAF  OR (95% CI) p  p 
rs11031006 11p14.1 30226528 FSHB 5’ upstream G 0.85 1.41  
(1.29-1.53) 
1.54×10
-9
  0.85 1.14 (1.06-1.22) 3×10
-3
  1.25×10
-10
 
rs17293443 15q22.33 67437863 SMAD3 Intron C 0.24 1.27  
(1.19-1.35) 
1.57×10
-8
  0.21 1.15 (1.07-1.23) 1.44×10
-4
  6.29×10
-11
 
rs12064669 1q42.13 230688643  Intergenic C 0.10 1.43 
(1.31-1.55) 
1.23×10
-8
  0.07 1.01 (0.89-1.13) 0.88  2.09×10
-7  
a
SNP position according to NCBI Human Genome Build 37; RAF, risk allele frequency; OR, odd ratio; 95% CI, 95% confidence interval 
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Table 24.  Association results for the implicated DZ twinning SNPs in fertility-related measures 
  rs11031006-G allele (near FSHB)  rs17293443-C allele (in SMAD3) 
DZ twinning and fertility-related measure  Effect  OR (95% CI) / 
Beta (95% CI) 
 p value  Effect  OR (95% CI) / 
Beta (95% CI) 
 p value 
DZ twinning
a
  Increase  1.41 (1.29, 1.53)  1.54×10
-9
  Increase  1.27 (1.19, 1.35)  1.57×10
-8 
FSH levels (SD units)
b
  Increase  0.11 (0.078, 
0.15) 
 2.3×10
-10
  ̶  0.016 (-0.014, 
0.045) 
 0.30 
Age at menarche (years)
c,d
  Earlier  -0.04 (-0.012, 
0.011) 
 8.5×10
-10
  Earlier̶  -0.001 (-0.127, 
0.010) 
 0.84 
Age at menopause (years)
e
  Earlier  -0.2165 (-0.065, 
0.052) 
 8.5×10
-14
  ̶  0.009 (-0.048, 
0.049) 
 ‒0.71 
Has children (yes/no)
f
  ̶  1.07 (0.98, 1.17)  0.12  ̶  0.96 (0.89, 1.04)  0.34 
Number of children
f
  Increase  0.014 (0.00091, 
0.27)
h
 
 0.03  ̶  0.0048 (-0.0062, 
0.016)
h
 
 0.39 
Age at first child (years)
f
  Earlier  -0.20 (-0.31, -
0.086) 
 5.3×10
-4
  ̶  0.032 (-0.065, 
0.13) 
 0.51 
Age at last child (years)
f
  Earlier  -0.097 (-0.21, 
0.015) 
 0.08  Later  0.14 (0.043, 
0.24) 
 4.7×10
-3
 
Average birth interval (years)
f
  ̶  0.015 (-0.037,  0.57  ̶  0.0051 (-0.040,  0.82 
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0.067) 0.050) 
PCOS
g
  Decrease  0.90 (0.84, 0.95)  12.39×10
-
49
 
 ̶  1.00 (0.96,1.05)  0.78 
a
MODZT GWAS;  
b
deCODE sample of 17,997 individuals with FSH levels; 
c,d
Lunetta 
d
Day et all . and Perry et al. (ref 21 and 2221) and Perry et al. (ref 22);  
e
Day et al. (ref 
2424) and Stolk et al. (ref 25); 
f
deCODE sample of 41,946 women; 
g
Polycystic ovary syndrome, Hayes Day et al. (ref 223); 
h
 factor of increase from log-linear model.. 
 
 
 
 
